Status:
COMPLETED
Corneal Oxygen Uptake With Apioc Contact Lenses
Lead Sponsor:
Lentechs, LLC
Conditions:
Contact Lens-Induced Corneal Disorder of Both Eyes (Diagnosis)
Eligibility:
All Genders
18-45 years
Phase:
NA
Brief Summary
The purpose of this research is to determine if a new investigational contact lens shape allows the eye to get more oxygen.
Eligibility Criteria
Inclusion
- Provide informed consent.
- Appear willing and able to adhere to instructions set forth in the protocol.
- Be between the ages of 18 and 45.
- Be an experienced contact lens wearer.
- Be an eyecare clinician or clinician-in-training.
- Flat and steep keratometry readings within 40 to 50D.
- Clear, healthy corneas with no irregular astigmatism.
- Normal, healthy conjunctiva in both eyes.
- Be able to provide corneal topography measurements.
- Be able to provide manifest refraction measurements.
Exclusion
- Irregular corneal astigmatism.
- Use of topical or systemic antihistamines within the previous week.
- Use of topical ophthalmic drops within the previous two days.
- History of corneal surgery.
- Currently pregnant or lactating.
- Systemic disease that would interfere with contact lens wear.
- Previous diagnosis of dry eye syndrome.
Key Trial Info
Start Date :
July 15 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 1 2022
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT04031118
Start Date
July 15 2019
End Date
November 1 2022
Last Update
October 10 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Rev1 Ventures
Columbus, Ohio, United States, 43212